入院高血糖可预测急性缺血性卒中后感染
本研究基于PASS多中心随机对照试验(n=2,550)数据,分析急性缺血性卒中患者入院高血糖(血糖≥7.8 mmol/L)与卒中后感染及功能结局的关系。在1,676例非糖尿病缺血性卒中患者中,338例(20%)存在入院高血糖;校正混杂因素后,入院高血糖与卒中后感染、3个月功能结局不良及3个月死亡相关。在418例已记录糖尿病患者中,入院高血糖与卒中后感染无关联。
要点
- 非糖尿病缺血性卒中患者入院血糖≥7.8 mmol/L与卒中后感染风险升高相关(aOR 2.31)。
- 入院高血糖还与非糖尿病患者的3个月功能结局不良(aOR 1.40)及死亡(aOR 2.11)相关。
- 在已记录糖尿病的患者中,入院高血糖与卒中后感染无显著关联(aOR 0.49)。
核心结论
- 在非糖尿病急性缺血性卒中患者中,入院高血糖与卒中后感染及更差的功能结局相关。
- 卒中后感染未改变入院高血糖对功能结局的影响。
研究设计与样本
- 基于PASS多中心随机对照试验数据,共纳入2,550例急性缺血性卒中患者。
- 入院高血糖定义为血糖≥7.8 mmol/L,卒中后感染由专家裁定委员会判定。
- 功能结局采用3个月改良Rankin量表评估。
主要发现
- 1,676例非糖尿病缺血性卒中患者中,338例(20%)存在入院高血糖。
- 校正混杂因素后,入院高血糖与卒中后感染相关(aOR 2.31,95% CI 1.31-4.07)。
- 入院高血糖与3个月功能结局不良相关(common aOR 1.40,95% CI 1.12-1.73)。
- 入院高血糖与3个月死亡相关(aOR 2.11,95% CI 1.40-3.19)。
- 在418例已记录糖尿病患者中,入院高血糖与卒中后感染无关联(aOR 0.49,95% CI 0.15-1.58)。
关键数值与推荐
- 入院高血糖阈值:血糖≥7.8 mmol/L。
- 非糖尿病患者卒中后感染:aOR 2.31(95% CI 1.31-4.07)。
- 非糖尿病患者3个月功能结局:common aOR 1.40(95% CI 1.12-1.73)。
- 非糖尿病患者3个月死亡:aOR 2.11(95% CI 1.40-3.19)。
- 糖尿病患者卒中后感染:aOR 0.49(95% CI 0.15-1.58)。
临床怎么用
- 对非糖尿病急性缺血性卒中患者,入院时血糖≥7.8 mmol/L提示卒中后感染及不良结局风险升高。
- 可将入院高血糖作为非糖尿病缺血性卒中患者感染风险分层与监测的参考指标。
局限性
- 在功能结局分析中额外校正卒中后感染后模型未见实质性改变,提示卒中后感染可能并非主要中介路径。
- 糖尿病患者中入院高血糖与卒中后感染无关联,相关解释需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether admission hyperglycemia predicts poststroke infections and, if so, whether poststroke infections modify the effect of admission hyperglycemia on functional outcome in ischemic stroke. METHODS: We used data from acute ischemic stroke patients in the Preventive Antibiotics in Stroke Study (PASS), a multicenter randomized controlled trial (n = 2,550) investigating the effect of preventive antibiotics on functional outcome. Admission hyperglycemia was defined as blood glucose ≥7.8 mmol/L and poststroke infection as any infection during admission judged by an expert adjudication committee. Functional outcome at 3 months was assessed with the modified Rankin Scale. RESULTS: Of 1,676 nondiabetic ischemic stroke patients, 338 (20%) had admission hyperglycemia. After adjustment for potential confounding variables, admission hyperglycemia was associated with poststroke infection (adjusted odds ratio [aOR] 2.31, 95% CI 1.31-4.07), worse 3-month functional outcome (common aOR 1.40, 95% CI 1.12-1.73), and 3-month mortality (aOR 2.11, 95% CI 1.40-3.19). Additional adjustment for poststroke infection in the functional outcome analysis, done to assess poststroke infection as an intermediate in the pathway from admission hyperglycemia to functional outcome, did not substantially change the model. In patients with recorded diabetes mellitus (n = 418), admission hyperglycemia was not associated with poststroke infection (aOR 0.49, 95% CI 0.15-1.58). CONCLUSIONS: In nondiabetic acute ischemic stroke patients, admission hyperglycemia is associated with poststroke infection and worse functional outcome. Poststroke infections did not modify the effect of admission hyperglycemia on functional outcome in ischemic stroke.
引用
- Zonneveld TP, Nederkoorn PJ, Westendorp WF, et al. Hyperglycemia predicts poststroke infections in acute ischemic stroke. Neurology. 2017. PMID: 28283600. doi:10.1212/WNL.0000000000003811
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。